Get started Log in

AURA — Aura Biosciences Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Brief: Aura Biosciences Reports Topline Data From A Study Of Belzupacap Sarotalocan (Au-011) VS Plaque Radiotherapy Supporting
22/06/2022 21:32
Brief: Aura Biosciences To Present Updated Belzupacap Sarotalocan Data On Multiple Studies
17/06/2022 12:47
Brief: Aura Biosciences Announces Publication Of Preclinical Data
27/05/2022 24:40
Brief: Aura Biosciences Reports Q1 2022 Results
12/05/2022 21:21
Brief: Aura Biosciences Reports Fourth Quarter Financial Results
23/03/2022 20:22
Brief: Aura Biosciences To Present Preclinical Data Demonstrating Applicability Of AU-011 In Bladder Cancer At 2022 ASCO Genitourinary Cancer Symposium
14/02/2022 22:06
Brief: Adage Capital Partners Dissolves Share Stake In 3M, Ups in GE, American Express
14/02/2022 16:05
Brief: Aura Biosciences Reports Third Quarter 2021 Financial Results And Provides Clinical Development And Operational Highlights
24/11/2021 21:09
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:38 AM
24/11/2021 16:38
Brief: Aura Biosciences Presents Final Phase 1B/2 Data For Its First Virus-Like Drug Conjugate, Au-011, In Patients With Choroidal Melanoma At The American Academy Of Ophthalmology 2021 Annual Meeting
15/11/2021 16:01
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
29/10/2021 08:59
Brief: Aura Biosciences Says IPO Of 5.40 Million Common Shares Priced At $14 per Share
29/10/2021 02:42